Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ibalizumab

Known as: Immunoglobulin G4, Anti-(Human CD4 (Antigen)) (Human-Mouse Monoclonal 5A8 Gamma-4-Chain), Disulfide with Human-Mouse Monoclonal 5A8 Kappa-Chain, Dimer 
A humanized monoclonal antibody against CD4, with anti-human immunodeficiency virus (HIV) activity. Ibalizumab binds to CD4, the primary receptor for… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
The pace of antibody therapeutics development accelerated in 2017, and this faster pace is projected to continue through 2018… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2018
2018
Background Ibalizumab, a humanized IgG4 monoclonal antibody, blocks the entry of human immunodeficiency virus type 1 (HIV‐1) by… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2013
2013
OBJECTIVES Passive immunization for the prevention of HIV-1 infection is currently being reenergized. The anti-CD4 monoclonal… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
In the absence of an effective HIV-1 vaccine, passive immunization using broadly neutralizing Abs or Ab-like molecules could… Expand
Is this relevant?
2011
2011
Ibalizumab (formerly TNX-355) is a first-in-class, monoclonal antibody inhibitor of CD4-mediated human immunodeficiency type 1… Expand
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Ibalizumab is a humanized monoclonal antibody that binds human CD4, the primary receptor for human immunodeficiency virus type 1… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
The majority of currently available agents for the treatment of HIV-1 infection act by targeting one of several intracellular… Expand
  • table 1
Is this relevant?
2010
2010
Ibalizumab is a humanized, anti-CD4 monoclonal antibody. It potently blocks HIV-1 infection and targets an epitope in the second… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Ibalizumab (formerly TNX-355) is a humanized monoclonal antibody that binds CD4, the primary receptor for human immunodeficiency… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2007
Review
2007
Tanox Inc (under license from Biogen Idec, formerly Biogen Inc) is developing ibalizumab, an intravenous, humanized, monoclonal… Expand
Is this relevant?